查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球加壓治療市場:按產品(繃帶,包裹物,長襪,膠帶,正畸牙套,泵),應用(靜脈曲張,DVT、淋巴水腫潰瘍),分銷渠道(醫院/診所,藥房,電子商務)預測至2027
市場調查報告書
商品編碼
1188886

全球加壓治療市場:按產品(繃帶,包裹物,長襪,膠帶,正畸牙套,泵),應用(靜脈曲張,DVT、淋巴水腫潰瘍),分銷渠道(醫院/診所,藥房,電子商務)預測至2027

Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel(Hospitals, Clinics, Pharmacies, E-Commerce) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 226 Pages | 訂單完成後即時交付

價格
簡介目錄

全球加壓療法市場規模預計將從 2022 年的 37 億美元增長到 2027 年的 49 億美元，複合年增長率為 5.5%。 糖尿病、靜脈性腿部潰瘍和深靜脈血栓形成的患病率上升，以及患有骨科疾病的老年人數量迅速增加，似乎正在推動加壓療法產品的普及。 此外，運動損傷的增加、在某些疾病的管理中使用加壓療法產品的良好臨床證據，以及全球主要參與者在加壓療法方面的新發展，預計將進一步支持市場增長。。

在產品中，預計壓縮泵部分在預測期內的增長率最高。 癌症發病率上升、慢性靜脈疾病患病率上升以及髖關節和膝關節手術增多等因素預計將在預測期內推動壓縮泵市場的增長。

按應用劃分，靜脈曲張治療領域將在 2021 年佔據最大的市場份額。 因素包括靜脈曲張患病率的增加以及加壓療法作為靜脈曲張一線治療的普及。

按地區劃分，預計亞太市場在預測期內將以最高複合年增長率增長。 這背後的因素包括糖尿病患者的增加、老年人口的增加、骨科疾病的增加以及醫療基礎設施的改善。

本報告分析了全球壓力治療市場，包括市場的基本結構和最新發展、主要市場驅動因素和製約因素，以及按技術、產品、應用、分銷渠道和區域劃分的市場。我們研究了市場前景趨勢，市場競爭狀況，主要公司概況等。

內容

第一章介紹

第二章研究方法論

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 市場動態
    • 動力
    • 約束因素
    • 機會
    • 任務
  • 波特的五力分析
  • 價格趨勢分析
  • 技術分析
    • 無線生物傳感器
    • 服裝製造技術
  • 監管分析
  • 贖回場景
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統分析
  • 專利分析
  • 貿易分析
  • 主要會議和活動 (2022-2023)
  • 主要利益相關者和採購標準

第 6 章加壓治療市場:按技術分類

  • 簡介
  • 靜態加壓療法
  • 動態加壓療法

第 7 章加壓療法市場:按產品分類

  • 簡介
  • 加壓繃帶
  • 壓縮包
  • 壓力襪
    • I 類壓力襪
    • II 類壓力襪
    • III 級壓力襪
  • 壓縮帶
  • 壓縮泵
    • 間歇泵
    • 連續泵
  • 壓縮支架
  • 其他緊身衣

第 8 章加壓治療市場:按應用

  • 簡介
  • 治療靜脈曲張
  • 深靜脈血栓形成 (DTV) 的治療
  • 淋巴水腫的治療
  • 腿部潰瘍的治療
  • 其他用途

第 9 章加壓治療市場:按分銷渠道

  • 簡介
  • 藥房/零售商
  • 電子商務平台
  • 醫院和診所
  • 家庭護理

第 10 章加壓治療市場:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲

第11章競爭格局

  • 簡介
  • 主要公司採用的策略
  • 收益分成分析
  • 市場份額分析
  • 競爭形勢和趨勢
  • 公司評估象限
  • 競爭領導力映射:企業評估象限(2021 年）
  • 競爭領導力映射:初創公司/中小企業評估象限(2021 年）
  • 競爭基準
  • 競爭場景
    • 產品發布
    • 資本交易
    • 其他趨勢

第12章公司簡介

  • 主要公司
    • 3M
    • ARJOHUNTLEIGH
    • BIO COMPRESSION SYSTEMS, INC.
    • BSN MEDICAL (ESSITY子公司)
    • CARDINAL HEALTH, INC.
    • CONVATEC INC.
    • DJO, LLC (COLFAX CORPORATION子公司)
    • JULIUS ZORN GMBH
    • MEDI GMBH & CO. KG
    • PAUL HARTMANN AG
    • SANYLEG S.R.L.
    • SIGVARIS GROUP
    • SMITH & NEPHEW PLC
    • TACTILE SYSTEMS TECHNOLOGY, INC. ("TACTILE MEDICAL")
    • MEGO AFEK LTD.
  • 其他企業
    • MEDLINE INDUSTRIES, LP
    • GOTTFRIED MEDICAL, INC.
    • THERMOTEK, INC.
    • BAUERFEIND AG
    • OFA BAMBERG GMBH
    • ACI MEDICAL, LLC
    • AIROS MEDICAL INC.
    • BARCELCOM TEXTEIS, S.A.
    • CIZETA MEDICALI S.P.A.
    • BOSL MEDIZINTECHNIK

第13章 附錄

簡介目錄
Product Code: MD 5515

The compression therapy market size is expected to grow from an estimated USD 3.7 billion in 2022 to USD 4.9 billion by 2027, at a CAGR of 5.5%. Rising global prevalence of diabetes, venus leg ulcer, deep vein thrombosis and rapid growth in the older population with orthopedic disorders are likely to boost the adoption of compression therapy products. Growing cases of sports injuries, favorable clinical evidence for the use of compression therapy products in the management of several diseases and new developments in compression therapy by global giants are further anticipated to support the growth of the market.

"Compression pumps segment is expected to witness the highest growth rate during the forecast period"

On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.

"varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application

On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,

" The Asia Pacific market is expected to grow at the highest CAGR during the forecast period"

The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%

By Designation: C-level-10%, Director-level-14%, and Others-76%

By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The major players operating in the compression therapy market are DJO, Inc. (US), BSN Medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), Smith & Nephew Plc (UK) and Mego Afek Ltd. (Israel).

Research Coverage

This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the compression therapy market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the compression therapy market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the compression therapy market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 LIMITATIONS
  • 1.6 KEY MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Indicative list of secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 RECESSION IMPACT
    • 2.3.1 IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET
  • 2.4 DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 8 COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET

4 PREMIUM INSIGHTS

  • 4.1 COMPRESSION THERAPY MARKET OVERVIEW
    • FIGURE 12 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH
  • 4.2 COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 2027
  • 4.5 COMPRESSION THERAPY MARKET, BY REGION, 2020-2027
    • FIGURE 16 ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large target patient population
    • FIGURE 18 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050
      • 5.2.1.2 Growing incidence of sports injuries and accidents
    • FIGURE 19 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021
      • 5.2.1.3 Increasing number of orthopedic procedures
      • 5.2.1.4 Greater product affordability and market availability
      • 5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of universally accepted standards for compression products
      • 5.2.2.2 Low patient compliance with compression garments
    • FIGURE 20 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential offered by emerging markets
      • 5.2.3.2 Growing patient awareness regarding benefits of compression therapy
      • 5.2.3.3 Increased sales of off-the-shelf and online products
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Significant adoption of alternative therapies for specific target indications
      • 5.2.4.2 Increasing pricing pressure on market players
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 OVERVIEW
    • TABLE 2 COMPRESSION THERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.2 BARGAINING POWER OF BUYERS
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 THREAT FROM NEW ENTRANTS
    • 5.3.5 THREAT FROM SUBSTITUTES
    • 5.3.6 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 PRICING TREND ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE, BY PRODUCT
    • TABLE 3 AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
    • 5.4.2 AVERAGE SELLING PRICE, BY REGION
    • TABLE 4 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD)
  • 5.5 TECHNOLOGY ANALYSIS
    • 5.5.1 WIRELESS BIOSENSORS
    • 5.5.2 GARMENT MANUFACTURING TECHNOLOGIES
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 NORTH AMERICA
      • 5.6.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.6.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.6.2 EUROPE
    • FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
    • 5.6.3 ASIA PACIFIC
      • 5.6.3.1 Japan
    • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.6.3.2 China
    • TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.6.3.3 India
  • 5.7 REIMBURSEMENT SCENARIO
    • TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.9 SUPPLY CHAIN ANALYSIS
    • 5.9.1 PROMINENT COMPANIES
    • 5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.9.3 END USERS
    • FIGURE 24 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
    • 5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS
  • 5.11 PATENT ANALYSIS
    • FIGURE 25 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • TABLE 11 IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017-2021 (USD)
    • TABLE 12 EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017-2021 (USD)
  • 5.13 KEY CONFERENCES & EVENTS, 2022-2023
    • 5.13.1 COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL
    • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%)
    • 5.14.2 BUYING CRITERIA
    • FIGURE 27 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL
    • TABLE 14 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL

6 COMPRESSION THERAPY MARKET, BY TECHNIQUE

  • 6.1 INTRODUCTION
    • TABLE 15 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
  • 6.2 STATIC COMPRESSION THERAPY
    • 6.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH
    • TABLE 16 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 DYNAMIC COMPRESSION THERAPY
    • 6.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET
    • TABLE 17 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020-2027 (USD MILLION)

7 COMPRESSION THERAPY MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 18 COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 7.2 COMPRESSION BANDAGES
    • 7.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH
    • TABLE 19 COMPRESSION BANDAGES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 20 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 21 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 22 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 7.3 COMPRESSION WRAPS
    • 7.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET
    • TABLE 23 COMPRESSION WRAPS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 24 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 25 COMPRESSION WRAPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 26 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 7.4 COMPRESSION STOCKINGS
    • TABLE 27 COMPRESSION STOCKINGS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 28 COMPRESSION STOCKINGS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 29 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 30 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 31 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 7.4.1 CLASS I COMPRESSION STOCKINGS
      • 7.4.1.1 Advantages such as comfort and durability to drive demand for class I stockings
    • TABLE 32 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 7.4.2 CLASS II COMPRESSION STOCKINGS
      • 7.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand
    • TABLE 33 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 7.4.3 CLASS III COMPRESSION STOCKINGS
      • 7.4.3.1 High level of compression provided to boost adoption of class III stockings
    • TABLE 34 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 COMPRESSION TAPES
    • 7.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES
    • TABLE 35 COMPRESSION TAPES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 36 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 37 COMPRESSION TAPES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 38 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 7.6 COMPRESSION PUMPS
    • TABLE 39 COMPRESSION PUMPS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 40 COMPRESSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 41 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 42 COMPRESSION PUMPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 43 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 7.6.1 INTERMITTENT PUMPS
      • 7.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand
    • TABLE 44 INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 7.6.2 SEQUENTIAL PUMPS
      • 7.6.2.1 Wide usage to prevent development of DVT to boost growth
    • TABLE 45 SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 7.7 COMPRESSION BRACES
    • 7.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET
    • TABLE 46 COMPRESSION BRACES MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 47 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 48 COMPRESSION BRACES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 49 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 7.8 OTHER COMPRESSION GARMENTS
    • TABLE 50 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 51 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 52 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 53 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

8 COMPRESSION THERAPY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 54 COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027(USD MILLION)
  • 8.2 VARICOSE VEIN TREATMENT
    • 8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET
    • TABLE 55 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 DEEP VEIN THROMBOSIS TREATMENT
    • 8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH
    • TABLE 56 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 LYMPHEDEMA TREATMENT
    • 8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH
    • TABLE 57 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.5 LEG ULCER TREATMENT
    • 8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET
    • TABLE 58 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020-2027 (USD MILLION)
  • 8.6 OTHER APPLICATIONS
    • TABLE 59 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)

9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 INTRODUCTION
    • TABLE 60 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 9.2 PHARMACIES & RETAILERS
    • 9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH
    • TABLE 61 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 E-COMMERCE PLATFORMS
    • 9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD
    • TABLE 62 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 HOSPITALS & CLINICS
    • 9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH
    • TABLE 63 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 HOME CARE SETTINGS
    • 9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET
    • TABLE 64 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2027 (USD MILLION)

10 COMPRESSION THERAPY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 65 COMPRESSION THERAPY MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT
    • TABLE 66 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 67 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 68 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 69 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 70 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising number of sports injuries to drive market growth
    • TABLE 71 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing incidence of target diseases to support growth
    • TABLE 72 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 73 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 74 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 75 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 76 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 77 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth
    • TABLE 78 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Rising prevalence of lymphedema and DVT to drive market
    • TABLE 79 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 High incidence of diabetes to drive demand for compression therapy
    • TABLE 80 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth
    • TABLE 81 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Growing presence of key manufacturers to increase access to compression therapy products
    • TABLE 82 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 83 HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES
    • TABLE 84 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT
    • TABLE 85 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Japan to dominate Asia Pacific compression therapy market
    • TABLE 90 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Modernization of healthcare facilities to drive market growth
    • TABLE 91 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing number of hip & knee surgeries to support market
    • TABLE 92 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Government subsidies related to compression garments for lymphedema patients to promote growth
    • TABLE 93 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Increasing number of plastic surgeries to drive demand for compression garments
    • TABLE 94 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 95 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 96 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 97 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 98 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 99 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 100 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Rising number of cosmetic surgeries to support market
    • TABLE 101 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Lack of reimbursement for bracing products to limit growth
    • TABLE 102 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 103 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH
    • TABLE 104 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
    • TABLE 105 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 106 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 107 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET
    • TABLE 108 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 31 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021
  • 11.5 COMPETITIVE SITUATIONS AND TRENDS
    • TABLE 109 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION
  • 11.6 COMPANY EVALUATION QUADRANT
  • 11.7 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • FIGURE 32 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
  • 11.8 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 STARTING BLOCKS
    • 11.8.3 RESPONSIVE COMPANIES
    • 11.8.4 DYNAMIC COMPANIES
    • FIGURE 33 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021)
  • 11.9 COMPETITIVE BENCHMARKING
    • FIGURE 34 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET
    • TABLE 110 COMPANY PRODUCT FOOTPRINT
    • TABLE 111 COMPANY REGIONAL FOOTPRINT
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES
    • 11.10.2 DEALS
    • 11.10.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

    • 12.1.1 3M
    • TABLE 112 3M: BUSINESS OVERVIEW
    • FIGURE 35 3M: COMPANY SNAPSHOT (2021)
    • 12.1.2 ARJOHUNTLEIGH
    • TABLE 113 ARJOHUNTLEIGH: BUSINESS OVERVIEW
    • FIGURE 36 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021)
    • 12.1.3 BIO COMPRESSION SYSTEMS, INC.
    • TABLE 114 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW
    • 12.1.4 BSN MEDICAL (A SUBSIDIARY OF ESSITY)
    • TABLE 115 ESSITY: BUSINESS OVERVIEW
    • FIGURE 37 ESSITY: COMPANY SNAPSHOT (2021)
    • 12.1.5 CARDINAL HEALTH, INC.
    • TABLE 116 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.6 CONVATEC INC.
    • TABLE 117 CONVATEC INC.: BUSINESS OVERVIEW
    • FIGURE 39 CONVATEC INC.: COMPANY SNAPSHOT (2021)
    • 12.1.7 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)
    • TABLE 118 DJO, LLC: BUSINESS OVERVIEW
    • FIGURE 40 COLFAX CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.8 JULIUS ZORN GMBH
    • TABLE 119 JULIUS ZORN GMBH: BUSINESS OVERVIEW
    • 12.1.9 MEDI GMBH & CO. KG
    • TABLE 120 MEDI GMBH & CO. KG: BUSINESS OVERVIEW
    • 12.1.10 PAUL HARTMANN AG
    • TABLE 121 PAUL HARTMANN AG: BUSINESS OVERVIEW
    • FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
    • 12.1.11 SANYLEG S.R.L.
    • TABLE 122 SANYLEG S.R.L.: BUSINESS OVERVIEW
    • 12.1.12 SIGVARIS GROUP
    • TABLE 123 SIGVARIS GROUP: BUSINESS OVERVIEW
    • 12.1.13 SMITH & NEPHEW PLC
    • TABLE 124 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
    • FIGURE 42 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
    • 12.1.14 TACTILE SYSTEMS TECHNOLOGY, INC. ("TACTILE MEDICAL")
    • TABLE 125 TACTILE MEDICAL: BUSINESS OVERVIEW
    • FIGURE 43 TACTILE MEDICAL: COMPANY SNAPSHOT (2021)
    • 12.1.15 MEGO AFEK LTD.
    • TABLE 126 MEGO AFEK LTD.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 MEDLINE INDUSTRIES, LP
    • 12.2.2 GOTTFRIED MEDICAL, INC.
    • 12.2.3 THERMOTEK, INC.
    • 12.2.4 BAUERFEIND AG
    • 12.2.5 OFA BAMBERG GMBH
    • 12.2.6 ACI MEDICAL, LLC
    • 12.2.7 AIROS MEDICAL INC.
    • 12.2.8 BARCELCOM TEXTEIS, S.A.
    • 12.2.9 CIZETA MEDICALI S.P.A.
    • 12.2.10 BOSL MEDIZINTECHNIK

Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS